Literature DB >> 24581528

Quality of life and health status among prostate cancer survivors and noncancer population controls.

Lixin Song1, Yingchun Ji2, Mathew E Nielsen3.   

Abstract

OBJECTIVE: To examine whether quality of life (QOL), health status, and the relationships between them varied by having a prostate cancer history. This study helps to inform the interface between aging-related health decline and the survival state among older men with prostate cancer, which is an important yet understudied public health issue.
METHODS: Hierarchical linear models were used to analyze the cross-sectional data from the nationally representative population-based Medical Expenditure Panel Survey. Using propensity score matching, survivors (respondents with prostate cancer history) and controls (respondents without a history of any cancer) (N = 193 pairs) were matched based on 7 sociodemographic and health-related factors. QOL was measured using the mental and physical component scores of the SF-12 (SF-36.org). Health status included comorbidities, activities of daily living (ADL), instrumental ADL, and depressed mood.
RESULTS: In bivariate analyses, survivors reported worse physical (42.72 vs 45.45 respectively; P = .0040) and mental QOL (51.59 vs 53.73 respectively; P = .0295) and more comorbidities (3.25 vs 2.78 respectively; P = .0139) than controls. In multivariate analyses, for both survivors and controls, better physical QOL was associated with fewer comorbidities (P <.0001), no need help with ADL (P = .0011) and IADL (P = .0162), and less depressed mood (P <.0001); better mental QOL was associated with no need help with IADL (P = .0005) and less depressed mood (P <.0001).
CONCLUSION: QOL of older men is affected by physical, functional, and psychological factors rather than prostate cancer history. Clinicians need to attend to aging-related health issues when providing care for prostate cancer survivors to improve QOL.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24581528      PMCID: PMC3947555          DOI: 10.1016/j.urology.2013.12.009

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  22 in total

1.  Assessing longitudinal quality of life in prostate cancer patients and their spouses: a multilevel modeling approach.

Authors:  Lixin Song; Laurel L Northouse; Thomas M Braun; Lingling Zhang; Bernadine Cimprich; David L Ronis; Darlene W Mood
Journal:  Qual Life Res       Date:  2010-10-08       Impact factor: 4.147

Review 2.  Recent trends in disability and functioning among older adults in the United States: a systematic review.

Authors:  Vicki A Freedman; Linda G Martin; Robert F Schoeni
Journal:  JAMA       Date:  2002-12-25       Impact factor: 56.272

3.  Factors associated with quality of life in older adults in the United States.

Authors:  Marianne Baernholdt; Ivora Hinton; Guofen Yan; Karen Rose; Meghan Mattos
Journal:  Qual Life Res       Date:  2011-06-25       Impact factor: 4.147

4.  How does initial treatment choice affect short-term and long-term costs for clinically localized prostate cancer?

Authors:  Claire F Snyder; Kevin D Frick; Amanda L Blackford; Robert J Herbert; Bridget A Neville; Michael A Carducci; Craig C Earle
Journal:  Cancer       Date:  2010-08-23       Impact factor: 6.860

5.  Recent changes in the health status of the older U.S. population: findings from the 1984 and 1994 supplement on aging.

Authors:  Y Liao; D L McGee; G Cao; R S Cooper
Journal:  J Am Geriatr Soc       Date:  2001-04       Impact factor: 5.562

6.  Burden of illness in cancer survivors: findings from a population-based national sample.

Authors:  K Robin Yabroff; William F Lawrence; Steven Clauser; William W Davis; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2004-09-01       Impact factor: 13.506

7.  Do older men benefit from curative therapy of localized prostate cancer?

Authors:  Shabbir M H Alibhai; Gary Naglie; Robert Nam; John Trachtenberg; Murray D Krahn
Journal:  J Clin Oncol       Date:  2003-09-01       Impact factor: 44.544

8.  Cancer survivors in the United States: age, health, and disability.

Authors:  Maria Hewitt; Julia H Rowland; Rosemary Yancik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2003-01       Impact factor: 6.053

9.  The Patient Health Questionnaire-2: validity of a two-item depression screener.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams
Journal:  Med Care       Date:  2003-11       Impact factor: 2.983

10.  Quality of life of men treated with brachytherapies for prostate cancer.

Authors:  Elise L Lev; Lucille Sanzero Eller; Glen Gejerman; Patricia Lane; Steven V Owen; Michele White; Njoki Nganga
Journal:  Health Qual Life Outcomes       Date:  2004-06-15       Impact factor: 3.186

View more
  4 in total

1.  Factors influencing the health-related quality of life of Chinese advanced cancer patients and their spousal caregivers: a cross-sectional study.

Authors:  Qiuping Li; Yinghua Xu; Huiya Zhou; Alice Yuen Loke
Journal:  BMC Palliat Care       Date:  2016-08-02       Impact factor: 3.234

2.  Racial and Ethnic Variation in Health-Related Quality of Life Scores Prior to Prostate Cancer Treatment.

Authors:  Stephanie R Reading; Kimberly R Porter; Jeffrey M Slezak; Teresa N Harrison; Joy S Gelfond; Gary W Chien; Steven J Jacobsen
Journal:  Sex Med       Date:  2017-08-18       Impact factor: 2.491

3.  Social and medical risk factors associated with supportive needs in the first year following localized prostate cancer treatment.

Authors:  Erin K Tagai; Shawna V Hudson; Michael A Diefenbach; Jenny Xu; Alicja Bator; Allison Marziliano; Suzanne M Miller
Journal:  J Cancer Surviv       Date:  2020-07-18       Impact factor: 4.442

4.  Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancer.

Authors:  Suzanne K Chambers; Shu Kay Ng; Peter Baade; Joanne F Aitken; Melissa K Hyde; Gary Wittert; Mark Frydenberg; Jeff Dunn
Journal:  Psychooncology       Date:  2017-01-11       Impact factor: 3.894

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.